VivoSeq
Musculoskeletal

Rotator Cuff Tears

2

Pipeline Programs

6

Active Trials

1

Companies Involved

Rotator Cuff Tears is an early-stage landscape with 2 programs across 1 company. The most active players are Amring.

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

15/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

9

clinical trials

Recruiting3 · 33%
Completed3 · 33%
Not yet recruiting2 · 22%
Active, not recruiting1 · 11%

Trial Activity

9 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)